Recurrent mutation of JAK3 in T‐cell prolymphocytic leukemia
暂无分享,去创建一个
R. Siebert | R. Russell | M. Dyer | C. López | R. Küppers | M. Schrappe | O. Ammerpohl | J. Dürig | U. Dührsen | M. Betts | A. Bergmann | A. Haake | M. Seifert | S. Jayne | I. Vater | Eva Maria Murga Penas | Sina Schneppenheim | R. Russell
[1] E. Montserrat,et al. T‐cell prolymphocytic leukaemia , 2021, Haematology.
[2] A. Zelenetz,et al. Acute lymphoblastic leukemia. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[3] P. Gaulard,et al. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma , 2014, Leukemia.
[4] E. Birney,et al. Pfam: the protein families database , 2013, Nucleic Acids Res..
[5] L. Zeng,et al. The effects of R683S (G) genetic mutations on the JAK2 activity, structure and stability. , 2013, International journal of biological macromolecules.
[6] S. Miyano,et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia , 2013, Nature Genetics.
[7] M. Heinrich,et al. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia , 2012, Leukemia.
[8] C. Ong,et al. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. , 2012, Cancer discovery.
[9] Yibing Shan,et al. Crystal structures of the Jak2 pseudokinase domain and the pathogenic mutant V617F , 2012, Nature Structural &Molecular Biology.
[10] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[11] Peer Bork,et al. SMART 7: recent updates to the protein domain annotation resource , 2011, Nucleic Acids Res..
[12] T. Waldmann,et al. FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma. , 2011, Blood.
[13] T. Naoe,et al. Array-based genomic resequencing of human leukemia , 2010, Oncogene.
[14] T. Boggon,et al. JAK3: a two-faced player in hematological disorders. , 2009, The international journal of biochemistry & cell biology.
[15] Reinhard Schneppenheim,et al. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition. , 2009, Cancer genetics and cytogenetics.
[16] Sandra A. Moore,et al. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. , 2009, Blood.
[17] J. O’Shea,et al. Janus kinases in immune cell signaling , 2009, Immunological reviews.
[18] A. Baruchel,et al. Activating mutations in human acute megakaryoblastic leukemia. , 2008, Blood.
[19] H. Kanegane,et al. Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome , 2008, British journal of haematology.
[20] R. Siebert,et al. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32) , 2007, Leukemia.
[21] Sandra A. Moore,et al. Activating alleles of JAK3 in acute megakaryoblastic leukemia. , 2006, Cancer cell.
[22] R. Siebert,et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. , 2006, The Journal of molecular diagnostics : JMD.
[23] L. Holm,et al. The Pfam protein families database , 2005, Nucleic Acids Res..
[24] R. Siebert,et al. Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci , 2003, Leukemia.
[25] T. Stankovic,et al. Recurrent ATM mutations in T-PLL on diverse haplotypes: no support for their germline origin. , 2001, Blood.
[26] D. Catovsky,et al. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T‐prolymphocytic leukaemia and Sezary syndrome , 2000, British journal of haematology.
[27] F. Sigaux,et al. Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. , 1998, Blood.
[28] L. Berg,et al. T cell development and activation in Jak3‐deficient mice , 1998, Journal of leukocyte biology.
[29] G. Russo,et al. Deregulated expression of TCL1 causes T cell leukemia in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. James,et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia , 1997, Nature Medicine.
[31] M. Dyer,et al. Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia , 1997, Nature Genetics.
[32] W. Leonard,et al. Role of the Common Cytokine Receptor γ Chain in Cytokine Signaling and Lymphoid Development , 1995, Immunological reviews.
[33] W. Leonard,et al. Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.
[34] M. Isobe,et al. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. , 1995, Blood.
[35] J. Johnston,et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) , 1995, Nature.
[36] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[37] M. Dyer,et al. The chromosomal translocation t(X;14)(q28;q11) in T-cell pro-lymphocytic leukaemia breaks within one gene and activates another. , 1993, Oncogene.
[38] F. Sigaux,et al. MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. , 1993, Oncogene.
[39] G. Barton,et al. Multiple protein sequence alignment from tertiary structure comparison: Assignment of global and residue confidence levels , 1992, Proteins.
[40] D. Catovsky,et al. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. , 1991, Cancer genetics and cytogenetics.
[41] J. Melo,et al. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia. , 1987, Hematologic pathology.
[42] C. Dearden. T-cell prolymphocytic leukemia , 2006, Medical oncology.
[43] R. Siebert,et al. Classical and Molecular Cytogenetics of Tumor Cells , 1999 .
[44] F. Sigaux,et al. Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations. , 1996, Blood.
[45] D. Catovsky,et al. Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia. , 1987, Blood.
[46] H. Lipson. Crystal Structures , 1949, Nature.